SCHEMBL6655035

SCHEMBL6655035

CCN(C(=O)c1ccc(N)s1)[C@@](CC)(CCC(=O)O)C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
THRB P10828 1/20 0.37
KMT2A Q03164 1/20 0.37
CHEK1 O14757 1/20 0.30
FYN P06241 1/20 0.30
PDGFRB P09619 1/20 0.30
PIM1 P11309 1/20 0.30
FGFR1 P11362 1/20 0.30
FLT1 P17948 1/20 0.30
GRK5 P34947 1/20 0.30
MAP2K2 P36507 1/20 0.30
MAPK8 P45983 1/20 0.30
CDK8 P49336 1/20 0.30
RPS6KA3 P51812 1/20 0.30
PRKX P51817 1/20 0.30
JAK3 P52333 1/20 0.30
LIMK1 P53667 1/20 0.30
BTK Q06187 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9817743 0.80 MEN1 (0.36) MEN1ALDH1A1CYP1A2THRBKMT2A
SCHEMBL6311889 0.79 ALDH1A1 (0.36) MEN1ALDH1A1CYP1A2THRBKMT2A
SCHEMBL9539333 0.74 CES2 (0.37) MEN1ALDH1A1CYP1A2THRBKMT2A
SCHEMBL9555905 0.74 THRB (0.32) MEN1ALDH1A1CYP1A2THRBKMT2A
SCHEMBL6308181 0.73 TPMT (0.34) MEN1ALDH1A1CYP1A2THRBKMT2A
SCHEMBL11042857 0.73 CHRM2 (0.45) MEN1ALDH1A1CYP1A2THRBKMT2A
SCHEMBL10965940 0.72 ALDH1A1 (0.38) MEN1ALDH1A1CYP1A2THRBKMT2A
SCHEMBL9731664 0.72 ALDH1A1 (0.36) MEN1ALDH1A1CYP1A2THRBKMT2A
SCHEMBL6648900 0.72 HPGD (0.34) MEN1ALDH1A1CYP1A2THRBKMT2A
Bicarbonate SCHEMBL9731441 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6762188-B1 INHIBITING THYMIDYLATE SYNTHASE; COLON, BREAST OR LUNG CARCINOMA SMITHKLINE BEECHAM CORPORATION 2004-07-13 US disclosed
EP-1199307-B1 Pharmaceutically active benzoquinazoline compounds WELLCOME FOUND (GB) 2004-02-25 EP disclosed
EP-1199307-A1 Pharmaceutically active benzoquinazoline compounds THE WELLCOME FOUNDATION LIMITED (GB) 2002-04-24 EP disclosed
US-6090941-A Pharmaceutically active benzoquinazoline compounds GLAXO WELLCOME INC. (US) 2000-07-18 US disclosed
US-5663337-A ENZYME, ANTITUMOR GLAXO WELLCOME INC. (US) 1997-09-02 US disclosed
US-5661155-A THYMIDYLATE SYNTHASE INHIBITOR; ADMINISTERING TO THE MAMMAL SUFFERING FROM LEUKEMIA OR TUMOR 2-(5-(((1,2-DIHYDRO-3-METHYL-1-OXOBENZO(F)QUINAZOLINE-9-YL) METHYL)AMINO)-1-OXO-2-ISOINDOLINYL)GLUTARIC ACID OR SALTS GLAXO WELLCOME INC. (US) 1997-08-26 US disclosed
US-5405851-A Administering benzoquinazoline thymidylate synthase inhibitors BURROUGHS WELLCOME CO. (US) 1995-04-11 US disclosed
EP-0535034-A1 PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1993-04-07 EP disclosed
US-5187167-A Antitumor agents IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-02-16 US disclosed
US-5081124-A Amino acid and polyamino acid derivatives, inhibitors of thymidylate synthetase IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-01-14 US disclosed
WO-1991019700-A1 PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1991-12-26 WO disclosed
EP-0239362-B1 ANTI-TUMOR AGENTS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-12-04 EP disclosed
EP-0239362-A2 Anti-tumor agents IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1987-09-30 EP disclosed